4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · IEX Real-Time Price · USD
18.35
-0.17 (-0.92%)
Jul 26, 2024, 4:00 PM EDT - Market closed
4D Molecular Therapeutics Market Cap
4D Molecular Therapeutics has a market cap or net worth of $948.76 million as of July 26, 2024. Its market cap has increased by 44.58% in one year.
Market Cap
948.76M
Enterprise Value
437.02M
1-Year Change
44.58%
Ranking
Category
Stock Price
$18.35
Market Cap Chart
Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has increased from $580.38M to $948.76M, an increase of 63.47%. That is a compound annual growth rate of 14.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 957.50M | 10.54% |
| Dec 29, 2023 | 866.20M | 20.41% |
| Dec 30, 2022 | 719.40M | 2.03% |
| Dec 31, 2021 | 705.10M | -28.63% |
| Dec 31, 2020 | 987.90M | 70.22% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharvaris | 961.17M |
| Humacyte | 959.82M |
| CareDx | 959.38M |
| Pacira BioSciences | 943.02M |
| Embecta | 942.91M |
| Immunome | 909.73M |
| Cronos Group | 905.37M |
| Nuvation Bio | 894.09M |